Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Circ Cardiovasc Imaging. 2009 Jul 21;2(5):373–381. doi: 10.1161/CIRCIMAGING.108.843227

Figure 2.

Figure 2

(A) myocardial glucose utilization uptake rate (MGUUpR) and (B) myocardial glucose utilization (MGU) in untreated (ZDF), Metformin-treated (ZDF+MET) and Rosiglitazone-treated (ZDF+ROSI) at week 14 (W14) and week 19 (W14). MGUUpR represents the intrinsic capacity of the heart to uptake glucose independent of the plasma concentration of glucose ([Glu]P) while MGU is derived by the relation MGU=MGUUpR*[Glu]P. *, denotes that the treatment effect is marginally insignificant compared to untreated rats (P=0.06). All resulted are presented as mean ± 1 SD.